COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1920: Articles 19191-19200  | Next

Short-term forecasting of COVID-19 in Germany and Poland during the second wave - a preregistered study
Bracher, J., Wolffram, D., Deuschel, J., Goergen, K., Ketterer, J. L., Ullrich, A., Abbott, S., Barbarossa, M. V., Bertsimas, D., Bhatia, S., Bodych, M., Bosse, N. I., Burgard, J. P., Fuhrmann, J., Funk, S., Gogolewski, K., Gu, Q., Heyder, S., Hotz, T., Kheifetz, Y., Kirsten, H., Krueger, T., Krymova, E., Li, M. L., Meinke, J. H., Niedzielewski, K., Ozanski, T., Rakowski, F., Scholz, M., Soni, S., Srivastava, A., Zielinski, J., Zou, D., Gneiting, T., Schienle, M.
10.1101/2020.12.24.20248826 — Posted: 2020-12-26
Surveillance of acute SARS-CoV-2 infections in school children and point-prevalence during a time of high community transmission in Switzerland
Kriemler, S., Radtke, T., Ulyte, A., Puhan, M. A., Ammann, P., Prado-Peralta, G., Berger, C.
10.1101/2020.12.24.20248558 — Posted: 2020-12-26
A New State-Space Epidemiological Model for Cost-Effectiveness Analysis of Non-Medical Interventions- A Study on COVID-19 in California and Florida
Deo, V., Grover, G.
10.1101/2020.12.24.20248830 — Posted: 2020-12-26
Extensive High-Order Complexes within SARS-CoV-2 Proteome Revealed by Compartmentalization-Aided Interaction Screening
Xu, W., Pei, G., Liu, H., Wang, J., Li, P.
10.1101/2020.12.26.424422 — Posted: 2020-12-26
Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2
Neerukonda, S. N., Vassell, R., Herrup, R., Liu, S., Wang, T., Takeda, K., Yang, Y., Lin, T.-L., Wang, W., Weiss, C. D.
10.1101/2020.12.26.424442 — Posted: 2020-12-26
Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay
Xue, T., Wu, W., Guo, N., Wu, C., Huang, J., Lai, L., Liu, H., Li, Y., Wang, T., Wang, Y.
10.1101/2020.12.24.424245 — Posted: 2020-12-26
Let the DOCTOR Decide Whom to Test: Adaptive Testing Strategies to Tackle the COVID-19 Pandemic
Liang, Y., Yadav, A.
10.1101/2020.12.18.20248498 — Posted: 2020-12-26
Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of Covid-19 death
Szekely, L., Bozoky, B., Bendek, M., Ostad, M., Lavignasse, P., Haag, L., Wu, J., Jing, X., Gupta, S., Saccon, E., Sonnerborg, A., Cao, Y., Bjornstedt, M., Szakos, A.
10.1101/2020.12.23.424172 — Posted: 2020-12-26 Discussion: Onsite | Offsite
The SARS-CoV-2 S1 spike protein mutation N501Y alters the protein interactions with both hACE2 and human derived antibody: A Free energy of perturbation study
Fratev, F.
10.1101/2020.12.23.424283 — Posted: 2020-12-26 Discussion: Onsite | Offsite
Genomic diversity of SARS-CoV-2 can be accelerated by a mutation in the nsp14 gene
Takada, K., Ueda, M. T., Watanabe, T., Nakagawa, S.
10.1101/2020.12.23.424231 — Posted: 2020-12-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).